[1] 王福生,张政,吴娟,等.慢加急性肝衰竭的定义与临床诊断:东西方的异同. 中华肝脏病杂志,2014,22: 481-483.
[2] Sarin SK, Kedarisetty CK, Abbas Z, et al.Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014. Hepatol Int, 2014, 8: 453-471.
[3] 中华医学会感染病学分会肝衰竭与人工肝学组、中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊疗指南. 中华肝脏病杂志,2006,14: 643-646.
[4] 中华医学会感染病学分会肝衰竭与人工肝学组、中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2012年版). 中华临床感染病杂志, 2012,5: 321-327.
[5] Papatheodoridis GV, Lampertico P, Manolakopoulos S, et al. Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review. J Hepatol, 2010, 53:348-356.
[6] Lee WM, Stravitz RT, Larson AM. Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011.Hepatology (Baltimore, Md.) 2012, 55:965-967.
[7] 叶一农,高志良. 乙型肝炎肝衰竭发生机制中的三重打击. 传染病信息,2009,22: 276-279.
[8] Liu Y, Kang YZ, Xia WZ, et al. Artificial and bioartificial liver support systems for acute and acute-on-chronic liver failure: a meta-analysis. Nan Fang Yi Ke Da Xue Xue Bao,2009,29: 1529-1532.
[9] 史桂茹, 张国顺, 李新, 等. 乙型肝炎肝硬化患者并发慢加急性肝衰竭影响因素分析. 中国综合临床, 2013,29: 785-787.
[10] 姚立鹏,胡爱荣,蒋素文,等. 核苷(酸)类似物治疗慢性重型乙型肝炎近期预后多因素分析. 中西医结合肝病杂志,2015,25: 58-62.
[11] 张俊勇,秦成勇,贾继东,等.肝硬化患者血清钠特点及含钠终末期肝病模型对预后的判断价值.中华肝脏病杂志,2012,20: 108-111. |
